At a glance
- Originator Kyorin Pharmaceutical
- Class Antibacterials; Cephalosporins; Small molecules
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 04 Aug 1998 No-Development-Reported for Bacterial infections in Japan (Unknown route)
- 16 Feb 1996 Preclinical development for Bacterial infections in Japan (Unknown route)